Phase 3 trials at EHA hint at new standards of care

New CLL guidelines favour first-line venetoclax

Real-world FL data back trial-level responses to CAR T

Avant sounds alarm over pharmacist prescribing push

EHA Hodgkin lymphoma guidelines centre novel agents

Phase 3 data point to new standard of care for R/R CLL

MORE NEWS

more news